Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Mieloproliferativo síndrome")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 9774

  • Page / 391
Export

Selection :

  • and

Plasma von Willebrand factor proteolysis in patients with chronic myeloproliferative disorders: no possibility of ex vivo degradation by calcium-dependent proteasesTATEWAKI, W; TAKAHASHI, H; TAKAKUWA, E et al.Thrombosis research. 1989, Vol 56, Num 2, pp 191-199, issn 0049-3848, 9 p.Article

Myeloproliferative disordersMURRAY, Jim.Clinical medicine. 2005, Vol 5, Num 4, pp 328-332, issn 1470-2118, 5 p.Article

Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with timeBAKER, R. I; MANOHARAN, A.European journal of haematology. 1988, Vol 40, Num 3, pp 267-272, issn 0902-4441Article

Myeloproliferative disordersLEVINE, Ross L; GILLILAND, D. Gary.Blood. 2008, Vol 112, Num 6, pp 2190-2198, issn 0006-4971, 9 p.Article

Haemangioblastic transformation of myeloproliferative disease?STRAUCHEN, James A; CUTTNER, Janet; HOLLAND, James F et al.British journal of haematology. 2007, Vol 138, Num 6, pp 819-821, issn 0007-1048, 3 p.Article

The myeloproliferative disordersCAMPBELL, Peter J; GREEN, Anthony R.The New England journal of medicine. 2006, Vol 355, Num 23, pp 2452-2466, issn 0028-4793, 15 p.Article

Syndromes myéloprolifératifs Philadelphie-négatifsCASSINAT, Bruno; KILADJIAN, Jean-Jacques.Hématologie (Montrouge). 2006, Vol 12, pp 47-50, issn 1264-7527, 4 p., NS2Conference Paper

Lessons from familial myeloproliferative disordersSKODA, Radek; PRCHAL, Josef T.Seminars in hematology. 2005, Vol 42, Num 4, pp 266-273, issn 0037-1963, 8 p.Article

Transient myeloproliferative disorderMOIZ, Bushra; SHAFLQ, Maria.Blood. 2012, Vol 120, Num 24, issn 0006-4971, p. 4672Article

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAGARWAL, Anupriya; BUMM, Thomas G. P; DEININGER, Michael W et al.Blood. 2008, Vol 112, Num 5, pp 1960-1970, issn 0006-4971, 11 p.Article

Genetics of myeloid malignancies : Pathogenetic and clinical implicationsFROHLING, Stefan; SCHOLL, Claudia; GILILAND, D. Gary et al.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6285-6295, issn 0732-183X, 11 p.Article

Facteurs pronostiques du syndrome hyperéosinophilique (étude de 40 observations) = Prognostic factors of the hypereosinophilic syndrome. A study of 40 patientsLEFEBVRE, C; BLETRY, O; DEGOULET, P et al.Annales de médecine interne (Paris). 1989, Vol 140, Num 4, pp 253-257, issn 0003-410XArticle

Effect of 13-cis-retinoic acid on survival of patients with myelodysplastic syndromeCLARK, R. E; JACOBS, A; LUSH, C. J et al.Lancet (British edition). 1987, Vol 1, Num 8536, pp 763-765, issn 0140-6736Article

Myeloproliferative neoplasmsPUBLICOVER, Amy; MEDD, Patrick.Clinical medicine. 2013, Vol 13, Num 2, pp 188-192, issn 1470-2118, 5 p.Article

Syndromes myéloprolifératifs Philadelphie-négatifsKILADJIAN, Jean-Jacques.Hématologie (Montrouge). 2007, Vol 13, pp 55-58, issn 1264-7527, 4 p., NS1Conference Paper

Mini Symposium sur les Syndromes MyéloprolifératifsBRIERE, J.Pathologie et biologie. 2001, Vol 49, Num 2, pp 138-183, issn 0369-8114Conference Proceedings

Role of Additional Novel Therapies in Myeloproliferative NeoplasmsFISKUS, Warren; GANGULY, Siddhartha; KAMBHAMPATI, Suman et al.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii, 959-980 [22 p.]Article

Treatment paradigms in the management of myeloproliferative disordersFRUCHTMAN, Steven M.Seminars in hematology. 2004, Vol 41, Num 2, pp 18-22, issn 0037-1963, 5 p., SUP3Article

Histomorphologische Befunde am Knochenmark bei chronischen myeloproliferativen Erkrankungen = Chronic myeloproliferative disorders: histomorphological findings of the bone marrowTHIELE, J; FISCHER, R.H + G. Zeitschrift für Hautkrankheiten. 1989, Vol 64, Num 10, pp 903-912, issn 0301-0481, 6 p.Article

Les syndromes myéloprolifératifs de l'enfant = Myeloproliferative syndromes in the childSCHAISON, G; CASTRO MALASPINA, H; NAJEAN, Y et al.Actualités hématologiques. 1984, Vol 18, pp 93-106, issn 0567-8757Article

Possible new LNK mutations in myeloproliferative neoplasmsHA, Jung-Sook; JEON, Dong-Seok.American journal of hematology. 2011, Vol 86, Num 10, pp 866-868, issn 0361-8609, 3 p.Article

Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment StrategiesTEFFERI, Ayalew; VAINCHENKER, William.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 573-582, issn 0732-183X, 10 p.Article

Blood cell activation in myeloproliferative neoplasmsCERVANTES, Francisco; ARELLANO-RODRIGO, Eduardo; ALVAREZ-LARRAN, Alberto et al.Haematologica (Roma). 2009, Vol 94, Num 11, pp 1484-1488, issn 0390-6078, 5 p.Article

Molecular basis of myelodysplastic/myeloproliferative neoplasmsREITER, Andreas; INVERNIZZI, Rosangela; CROSS, Nicholas C. P et al.Haematologica (Roma). 2009, Vol 94, Num 12, pp 1634-1638, issn 0390-6078, 5 p.Article

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesABDEL-WAHAB, Omar; MULLALLY, Ann; HUBERMAN, Kety et al.Blood. 2009, Vol 114, Num 1, pp 144-147, issn 0006-4971, 4 p.Article

  • Page / 391